PUBLISHER: SkyQuest | PRODUCT CODE: 1205828
PUBLISHER: SkyQuest | PRODUCT CODE: 1205828
Global C-reactive Protein Testing Market was valued at USD 1.74 billion in 2021 and it is expected to reach a value of USD 1.96 billion by 2028, at a CAGR of 1.7% over the forecast period (2022-2028).
The development of portable bioanalytical tests with high specificity and sensitivity, quick reaction times, and multiplexing capabilities for on-site precise disease diagnosis and monitoring is anticipated to benefit greatly from advancements in nanotechnological techniques.
Top-down and bottom-up approaches were used to estimate and validate the size of the global C-reactive protein testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global C-reactive protein testing market is segmented on the basis of assay type, disease area, end-use, and region. By assay type, the market is segmented into immunoturbidimetric assay, chemiluminescence immunoassay, ELISA, and others. By disease area, the market is categorized into cardiovascular diseases, cancer, lupus, endometriosis, and others. By end-use, the market is classified into clinics, hospitals, laboratories, and others. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.
Due to their diverse optical properties, plasmonic nanoparticles (PNPs) are one of the technologies that can be used for biosensing applications. Researchers from Babe-Bolyai University in Romania offered an overview of plasmonic nanoparticles-based assays for the detection of C-reactive protein (CRP) in a report that was published in July 2021. The study also showed how to employ newly created point-of-care assays for quick CRP testing. In the near future, it is projected that these developments will hasten market expansion. During the anticipated time period, these innovations will fuel market expansion.
The main factors expected to hinder the growth of the global C-reactive protein testing market during the forecast period are likely to be a lack of knowledge about CRP testing and the absence of these cutting-edge technologies in low-medium sized economies worldwide. Additionally, it is anticipated that the high cost of these testing methods and the large initial setup investment will restrain market expansion.
C-reactive protein is one of the markers that can be utilized for assessing the severity of infection prognostics and therapy monitoring, according to IFCC recommendations. Chinese guidelines also say that CRP tests can be used in conjunction with other clinical parameters to assess and monitor SARS-CoV-2 infection. Products from businesses like Abbott and Aidian are available for use as supporting diagnostic tools in the treatment of COVID-19 infection.